PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
October 1, 2025Journal of Clinical Sleep Medicine

Nocturnal cerebral oxygenation in patients with COPD at altitude: data from a randomized clinical trial of acetazolamide

View Full Paper
Ask AI
Bookmark
Share

Authors

YSYaël Anne SchmuzigerMMMaamed MademilovABAline Buergin

Discussion

Loading...

Member takes

Overview

Randomized trial finds acetazolamide improves cerebral oxygenation in COPD patients, indicating potential benefit at high altitude.

Key Points

  • Acetazolamide significantly improved nocturnal cerebral oxygenation in COPD patients at altitude.
  • A decrease in both cerebral tissue oxygenation and arterial oxygen saturation occurred during elevation.
  • Mixed linear regression analysis was used to evaluate altitude impacts on cerebral oxygenation.
  • Findings highlight the need for preventive measures against altitude-related deoxygenation in COPD patients.

Cite This Study

Schmuziger et al. (2025) studied this question.

synapsesocial.com/papers/68dd91cffe798ba2fc498b88https://doi.org/10.5664/jcsm.11868
View Full Paper
Ask AI
Bookmark
Share